InvestorsHub Logo
Followers 74
Posts 15839
Boards Moderated 0
Alias Born 04/26/2010

Re: north40000 post# 94657

Tuesday, 10/25/2016 1:07:49 PM

Tuesday, October 25, 2016 1:07:49 PM

Post# of 424162
Shire priced Xiidra at the exact same cost of Restasis - double what a scrip for V would cost, and V has so many other benefits too - really wish AMRN could afford to do a DES trial!

http://www.fiercepharma.com/marketing/shire-targets-allergan-market-share-par-xiidra-pricing

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News